JP4223237B2 - ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法 - Google Patents

３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法 Download PDF

Info

Publication number
JP4223237B2
JP4223237B2 JP2002185044A JP2002185044A JP4223237B2 JP 4223237 B2 JP4223237 B2 JP 4223237B2 JP 2002185044 A JP2002185044 A JP 2002185044A JP 2002185044 A JP2002185044 A JP 2002185044A JP 4223237 B2 JP4223237 B2 JP 4223237B2
Authority
JP
Japan
Prior art keywords
carbon atoms
formula
compound
alkyl group
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2002185044A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003026677A (ja
Inventor
シェーン ウーヴェ
メッシンガー ヨーゼフ
ブリュックナー ラインハルト
ツィーグラー ディーター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AbbVie Pharmaceuticals GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of JP2003026677A publication Critical patent/JP2003026677A/ja
Application granted granted Critical
Publication of JP4223237B2 publication Critical patent/JP4223237B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2002185044A 2001-06-28 2002-06-25 ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法 Expired - Fee Related JP4223237B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10131217.2 2001-06-28
DE10131217A DE10131217A1 (de) 2001-06-28 2001-06-28 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
JP2003026677A JP2003026677A (ja) 2003-01-29
JP4223237B2 true JP4223237B2 (ja) 2009-02-12

Family

ID=7689787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002185044A Expired - Fee Related JP4223237B2 (ja) 2001-06-28 2002-06-25 ３−フェニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、これを含有する医薬品、その使用及びその製法

Country Status (29)

Country Link
US (1) US6602880B2 (enExample)
EP (1) EP1270576B1 (enExample)
JP (1) JP4223237B2 (enExample)
KR (1) KR20030002304A (enExample)
CN (1) CN1303082C (enExample)
AR (1) AR033772A1 (enExample)
AT (1) ATE276254T1 (enExample)
AU (1) AU781333B2 (enExample)
BR (1) BR0202419A (enExample)
CA (1) CA2391915C (enExample)
CZ (1) CZ296878B6 (enExample)
DE (2) DE10131217A1 (enExample)
DK (1) DK1270576T3 (enExample)
DZ (1) DZ3235A1 (enExample)
ES (1) ES2229020T3 (enExample)
HU (1) HUP0202057A3 (enExample)
IL (1) IL150431A0 (enExample)
MX (1) MXPA02006225A (enExample)
NO (1) NO20023112L (enExample)
NZ (1) NZ519811A (enExample)
PL (1) PL207995B1 (enExample)
PT (1) PT1270576E (enExample)
RU (1) RU2299210C2 (enExample)
SI (1) SI1270576T1 (enExample)
SK (1) SK5862002A3 (enExample)
TR (1) TR200402391T4 (enExample)
TW (1) TWI256393B (enExample)
UA (1) UA76707C2 (enExample)
ZA (1) ZA200204063B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
JP4948392B2 (ja) * 2004-03-29 2012-06-06 レ ラボラトア セルビエ 固形薬学的組成物を調製するためのプロセス
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
CN102875550B (zh) * 2011-07-12 2016-01-06 常州合全药业有限公司 1,3,7-三取代-3,7-二氮杂双环[3,3,1]壬烷衍生物及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658558A1 (de) 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
US4742217A (en) * 1986-06-02 1988-05-03 Honeywell Inc. Projection alignment and focusing aid
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4402933A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4402931A1 (de) 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Phenylsulfonyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NO20023112L (no) 2002-12-30
BR0202419A (pt) 2003-04-29
KR20030002304A (ko) 2003-01-08
US20030109541A1 (en) 2003-06-12
JP2003026677A (ja) 2003-01-29
ES2229020T3 (es) 2005-04-16
SI1270576T1 (en) 2005-02-28
DE50200996D1 (de) 2004-10-21
UA76707C2 (uk) 2006-09-15
HUP0202057A3 (en) 2003-05-28
EP1270576A3 (de) 2003-03-12
TWI256393B (en) 2006-06-11
SK5862002A3 (en) 2003-01-09
EP1270576B1 (de) 2004-09-15
HK1051860A1 (en) 2003-08-22
TR200402391T4 (tr) 2004-12-21
DE10131217A1 (de) 2003-01-09
AR033772A1 (es) 2004-01-07
HUP0202057A2 (hu) 2003-01-28
MXPA02006225A (es) 2005-02-17
AU781333B2 (en) 2005-05-19
RU2002117066A (ru) 2004-02-20
CA2391915A1 (en) 2002-12-28
CN1303082C (zh) 2007-03-07
CZ20021856A3 (cs) 2003-02-12
IL150431A0 (en) 2002-12-01
PL354774A1 (en) 2002-12-30
PT1270576E (pt) 2004-11-30
HU0202057D0 (enExample) 2002-09-28
DZ3235A1 (fr) 2005-04-20
AU5064402A (en) 2003-01-02
NZ519811A (en) 2004-03-26
CA2391915C (en) 2010-08-24
CN1394860A (zh) 2003-02-05
EP1270576A2 (de) 2003-01-02
NO20023112D0 (no) 2002-06-27
PL207995B1 (pl) 2011-02-28
DK1270576T3 (da) 2004-10-11
CZ296878B6 (cs) 2006-07-12
ATE276254T1 (de) 2004-10-15
RU2299210C2 (ru) 2007-05-20
US6602880B2 (en) 2003-08-05
ZA200204063B (en) 2003-01-23

Similar Documents

Publication Publication Date Title
EP3828168B1 (en) Two-quaternary ammonium compound and preparation method and use thereof
JPH07119222B2 (ja) Ｒ（＋）―テラゾシン
JPS62167752A (ja) フエニルアセトニトリル誘導体その医薬組成物および哺乳動物におけるカルシウムイオンきつ抗作用または抗高圧作用促進方法
JP3065659B2 (ja) 抗不整脈性第三級アミン―アルケニル―フェニル―アルカンスルホンアミド
WO2003080556A1 (en) Amine derivative with potassium channel regulatory function, its preparation and use
JP3853389B2 (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、その製法及び抗不整脈剤
RU2122546C1 (ru) N-//1-/4-/4-фторфенокси/бутил/-4-пиперидинил/-n-метил-амино/-2-бензтиазолы или их фармацевтически приемлемые соли присоединения кислоты, способ их получения, антиаритмическая композиция iii класса и способ ее получения
AU781333B2 (en) 3-phenyl-3, 7-diazabicyclo (3.3.1) nonane compounds and process for their preparation and medicaments containing these compounds
HU207511B (en) Process for producing pirimidinium derivatives, nonionic formes of them and pharmaceutical compositions containing them
DE69022442T2 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
JP3762799B2 (ja) 抗不整脈剤及びその製法
JPS62161768A (ja) ３（２ｈ）―ピリダジノン誘導体及びこれを含む薬剤組成物
AU2013249868B2 (en) Fluorinated benzofuran derivatives
JP2004506719A (ja) サリポルフィンまたはその誘導体の心臓疾患治療への応用およびその製法
NO135590B (enExample)
JP3846899B2 (ja) メタンスルホンアミドの抗不整脈（ｓ）−エナンチオマー
JPH0344371A (ja) 新規１，４―ジヒドロピリジン誘導体
KR910004674B1 (ko) 부정맥치료제
HU189726B (en) Process for preparing trans-4ar-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-1h/2h/-pyrazolo/3,4-g/quinoline
JPH09504787A (ja) 抗不整脈活性を有する複素環カルボキサミド誘導体
JP2006316064A (ja) ３（２ｈ）−ピリダジノン誘導体及びこれら化合物の使用
HK1051860B (en) 3-phenyl-3,7-diazabicyclo[3,3,1]nonane compounds and process for their preparation and medicaments containing these compounds
JPH07188139A (ja) アミド化合物
JPH11228412A (ja) 心筋選択的カルシウム拮抗薬
JPH10505829A (ja) 抗不整脈活性を有する４−（４−メタンスルホンアミドフェニル）ブチルアミン誘導体

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20081024

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20081119

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111128

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees